Adolescent cannabis use is an independent risk factor for future hypomania—often experienced as part of bipolar disorder—finds new research led by University of Warwick

Mislabeling may lead to adverse effects for patients, including children with epilepsy

Collaborative agreement will focus on researching and developing safer pharmaceutical cannabis-based products and moving these products through clinical trials using FDA guideline

Recent publication states 'store-front' system has elements that work well

Agilent's technology is helping industries advance discovery and development in cannabinoid research and assisting regulators in upholding hemp product safety and quality standards

As the industry grows, so does the increased need for potency testing.

Cannabis testing is an integral part of determining product safety and effectiveness 

Join Lab Manager our panel of experts as we review some of the latest tools and technologies for the cannabis lab in this interactive webinar presentation

The results were based on an open-label study of 81 patients—42 children and 39 adults—who experienced four or more seizures per month

“The structure is an important step toward explaining how cannabinoids initiate signals in the brain that affect the release of neurotransmitters that relay messages between the brain’s neurons,” researcher says

Researchers present evidence in mice for compound to treat pain without addiction risk or 'marijuana high' at world's leading neuroscience conference

Researchers from the Yale School of Public Health sampled more than 500 people living in five states where marijuana legalization is on voting ballots for 2016 Election Day